AMD to report Q1 earnings as AI, tariffs remain in focus
AMD (AMD) will report its first quarter earnings after the bell on Tuesday, providing a look at the impact of President Trump's tariffs on chip sales and a look at the health of the AI trade ahead of Nvidia's (NVDA) earnings later this month.
AMD's announcement follows rival Intel's (INTC) report, which saw the company beat on the top and bottom lines, but issue lighter than anticipated revenue guidance in the second quarter. At the time, Intel CFO David Zinsner blamed the 'current macro environment' for creating 'elevated uncertainty across the industry.'
PC makers produce a number of their products in China, as well as Vietnam and Malaysia. Computers are currently exempt from Trump's tariffs, but the administration has said it could implement duties on semiconductors based on the results of the Commerce Department's Section 232 investigation.
For the quarter, AMD is expected to report adjusted earnings per share (EPS) of $0.94 on revenue of $7.1 billion. The company saw EPS of $0.62 and revenue of $5.4 billion in the same quarter last year. Data Center segment revenue is expected to bring in $3.6 billion in the quarter compared to $2.3 billion last year.
In April, AMD, like Nvidia (NVDA), announced that the Trump administration instituted tighter export controls on AI chips destined for China. The move effectively cuts off AMD's ability to ship its MI308 AI processor to the region, and, according to the company, might result in as much as an $800 million charge on inventory, purchases commitments, and related reserves.
And that could weigh on the company's Q2 outlook.
Lisa Su, chairwoman and CEO of Advanced Micro Devices (AMD), delivers the opening keynote speech at Computex 2024, Taiwan's premier tech expo, in Taipei on June 3, 2024. (Photo by I-Hwa CHENG / AFP) (Photo by I-HWA CHENG/AFP via Getty Images)
·
I-HWA CHENG via Getty Images
'We expect AMD to post higher results and guide lower given 1Q strength for MI308, but turning into a headwind in 2Q with the AI chip ban into China,' KeyBanc analyst John Vinh wrote in an investor note ahead of AMD's earnings announcement.
AI stocks took a major hit over the past few months on fears that the trade has been overhyped. DeepSeek's January announcement that it managed to produce high-performance AI models using less than top-of-the-line chips further hammered chip stocks.
Shares of AMD are off 18% year-to-date and 36% over the last 12 months. Nvidia is down 15% year-to-date, but still up 22% over the last year.
'Unfortunately for AMD the AI story, already somewhat tenuous, is likely to take another material haircut on the back of new China sanctions (note that every $1B is ~25 cents in earnings) and overall remains uncompetitive in our view,' Bernstein analyst Stacy Rasgon wrote in an investor note.
AI chip companies are also staring down the government's AI diffusion rules, which would require certain countries to acquire special licenses to gain access to a limited number of US AI chips.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Forbes
12 minutes ago
- Forbes
Trump Budget Drops Protections For State Medical Cannabis Programs
The White House budget request for 2026 omits language that has protected state-regulated medical ... More cannabis operators from federal prosecution for more than decade. The Trump administration's budget request for the 2026 fiscal year drops provisions that have protected state medical cannabis programs for more than a decade, online cannabis news outlet Marijuana Moment reported on Monday. The budget provision has blocked federal law enforcement agencies from spending resources to investigate or prosecute businesses operating in compliance with state-authorized medical cannabis programs, despite the continued prohibition of marijuana under federal law. 'This provision, which has been in place since 2014, protects patients, caregivers, and medical cannabis providers in the 39 states that have legalized medical access from federal interference or criminal prosecution,' the National Organization for the Reform of Marijuana Laws (NORML) wrote in a statement. 'Prior to the passage of this protection, federal prosecutors routinely took actions against patients and dispensaries in legal states.' The budget restriction was first adopted by Congress in 2014 and has been included in the federal budget every year since. But the Trump administration's budget request for the 2026 fiscal year released last week does not include the language. Similarly, the budget requests for each of the four years of President Donald Trump's first term omitted the protections for state-regulated medical cannabis operators. The administration of President Barack Obama also left the language prohibiting federal interference with regulated medical marijuana businesses out its budget requests following the initial adoption of the provisions. By contrast, the administration budget requests for all fours years of Joseph Biden's presidency included the protections for state-legal medical marijuana businesses. While the budget request illustrates the Trump administration's spending policies and priorities, Congress has the constitutional responsibility and authority for appropriations legislation. The congressional budget has included the language every year since 2014, despite attempts by both Democratic and Republican administrations to drop the provision. 'Today, more than half the country, including 36 states and Washington, D.C., have embraced medical marijuana, and for the past 10 years, the Rohrabacher-Farr Amendment has prevented the Department of Justice from using federal funds to stop states from implementing their medical marijuana programs,' Laura A. Bianchi, co-founding partner of the cannabis and psychedelics law firm Bianchi and Brandt, writes in an email. 'Rolling back these protections would mark a significant setback for marijuana reform. Ultimately, Congress will have the final say, and the industry remains hopeful that they will uphold these vital safeguards.' When Trump signed previous appropriations bill including the protections for medical cannabis operators after requesting they be removed, his administration issued a statement that it 'will treat this provision consistent with the President's constitutional responsibility to faithfully execute the laws of the United States.' The statement, which was issued on three separate occasions, was widely interpreted to suggest that the Trump administration might ignore the budget restriction. The omission of the protections for state-legal medical cannabis programs in the Trump administration's 2026 budget request is likely to disappoint supporters of cannabis policy reform who were encouraged by the president's apparent support for decriminalizing marijuana during the 2024 election campaign. In September, Trump suggested he supported reclassifying marijuana under federal drug laws and that he would back state efforts to legalize recreational cannabis. 'As President, we will continue to focus on research to unlock the medical uses of marijuana to a Schedule 3 drug, and work with Congress to pass common sense laws, including safe banking for state authorized companies, and supporting states rights to pass marijuana laws, like in Florida, that work so well for their citizens,' Trump wrote on Truth Social, according to a report from Marijuana Moment.


Bloomberg
12 minutes ago
- Bloomberg
China In Wait and See Mode: Cameron Johnson
US-China trade talks do not appear to be progressing as President Trump said via social media, China's leader Xi Jinping is "extremely hard to a deal with." Tidalwave Solutions Senior Partner Cameron Johnson has more on the story. (Source: Bloomberg)


Washington Post
16 minutes ago
- Washington Post
Tracking Trump: The budget bill's projected cost; steel tariffs double; CDC coronavirus adviser quits; and more
A report found that the GOP budget bill will add $2.4 trillion to the deficit. Russia-Ukraine peace is not happening soon, according to President Donald Trump. Tariffs on steel and aluminum doubled to 50 percent. Trump complained he can't make a trade deal with China. The Trump administration ended an emergency abortion requirement.